Key facts
- It has raised $31.5M; the latest was Later Stage VC in Jan 2025.
- Notable investors include Legend Capital, Lotus Lake Ventures, Wuxi High-tech Zone Venture Capital Holding Group, First Capital Investment Management Co., Shanghai Tianyi Industrial Holdings Group — 11 tracked in total.
- Status: Privately Held (backing).
Investors
11+- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Hisky Medical
- ·The full record, as it builds
Funding rounds
No funding rounds for Hisky Medical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Hisky Medical
Developer of non-invasive medical devices designed to offer treatment for liver fibrosis. The company's devices offer monitoring methods to diagnose liver related diseases at an early stage in order to prevent the growth of the diseases, enabling liver doctors to ensure fast recovery of their patients and offer advanced treatment and cure.
- Sector
- Healthcare
- HQ
- Beijing, China
- Founded
- 2010
- Website
- hiskymedical.com/
- Ownership
- Privately Held (backing)
Hisky Medical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Hisky Medical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Hisky Medical in its N-PORT filings yet. We sweep new filings monthly.